Latest News about EXEL
Recent news which mentions EXEL
Bristol Myers Squibb-Exelixis Highlight Three-Year Follow Up Data From Opdivo+Cabometyx Combo Therapy In Kidney Cancer
February 14, 2023
From Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2023
February 14, 2023
From Motley Fool
2 Biotech Stocks You Can Buy and Hold for the Next Decade
February 12, 2023
From Motley Fool
3 No-Brainer Stocks to Buy Right Now for Less Than $25
February 04, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
January 26, 2023
From Benzinga
Exelixis' Patent Decision In Line With Expectations, But Analysts Say Stock Overhang Could Continue
January 20, 2023
Tickers
EXEL
From Benzinga
7 Biotech Stocks That Will Make You Rich in 10 Years
January 18, 2023
From InvestorPlace
Is Exelixis Stock a Buy Now?
December 29, 2022
From Motley Fool
2 Top Biotech Stocks to Buy for the Long Haul
December 25, 2022
From Motley Fool
2 Beaten-Down Growth Stocks to Buy Before the Bull Run
December 21, 2022
From Motley Fool
From Motley Fool
Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices
December 13, 2022
From MarketWatch
Nasdaq Bear Market: 5 Exceptionally Cheap Growth Stocks You'll Regret Not Buying on the Dip
December 10, 2022
From Motley Fool
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
December 09, 2022
From Benzinga
3 Stocks to Buy Hand Over Fist in December
December 03, 2022
From Motley Fool
From Motley Fool
The Smartest Stocks to Buy With $20 Right Now
November 16, 2022
From Motley Fool
2 No-Brainer Stocks to Buy Right Now for Less than $20
November 12, 2022
From Motley Fool
Here's Why This Growth Stock Is Already My 2022 Winner
November 09, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.